Dr. Stephenson on 2 Years Following the Management of Localized Prostate Cancer

Andrew J. Stephenson, MD, director for the Center of Urologic Oncology at the Cleveland Clinic, discusses the significance of a study investigating urinary, bowel, and sexual function at 2 years following the management of localized prostate cancer.

This is the first comparative study among 4 different treatments, explains Stephenson. This gives patients information regarding what to expect over the next 2 years with each treatment option.

According to Stephenson, it is important to balance the cancer control so as not to jeopardize a patient’s curability at the expense of quality of life.